[Doubling time of progression-free survival by palbociclib in metastatic breast cancer]

Authors :: L'Allemain, Gilles
Institut de Biologie Valrose (IBV)
Université Nice Sophia Antipolis (... - 2019) (UNS)
COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA)
Source :: Bulletin du Cancer, Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (4), pp.300
Publication Year :: 2015
Publisher :: HAL CCSD, 2015.
Abstract: International audience

Subjects :: MESH: Humans
MESH: Pyridines
MESH: Piperazines
MESH: Antineoplastic Agents
MESH: Clinical Trials, Phase II as Topic
MESH: Female
[SDV.BDD]Life Sciences [q-bio]/Development Biology
ComputingMilieux_MISCELLANEOUS
MESH: Breast Neoplasms

Language :: English
ISSN :: 00074551 and 17696917
Database :: OpenAIRE
Journal :: Bulletin du Cancer, Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (4), pp.300
Accession number :: edsair.dedup.wf.001..a893094be0243bbd482d24d5dff922ea

Tools